Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizo-Affective Disorder”

805 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 805 results

Large-scale testing (Phase 3)Study completedNCT00714818
What this trial is testing

Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness

Who this might be right for
SchizophreniaBipolar DisorderSchizoaffective Disorder
University of British Columbia 13
Post-approval studies (Phase 4)Study completedNCT00253110
What this trial is testing

A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Janssen, LP 396
Not applicableStudy completedNCT07673718
What this trial is testing

Α-N-acetylgalactosaminidase in Schizoaffective Disorder

Who this might be right for
Schizoaffective Disorder
Elazığ Mental Health and Diseases Hospital 93
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Post-approval studies (Phase 4)Study completedNCT00044187
What this trial is testing

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Who this might be right for
SchizophreniaPsychotic DisordersBipolar Disorder
Eli Lilly and Company 130
Post-approval studies (Phase 4)Study completedNCT01136772
What this trial is testing

A Comparison of Long-acting Injectable Medications for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 311
Testing effectiveness (Phase 2)Study completedNCT01400477
What this trial is testing

Nicotinic Receptors and Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
University of Colorado, Denver 97
Not applicableEnded earlyNCT06134661
What this trial is testing

Accelerated rTMS for Psychomotor Slowing

Who this might be right for
Schizophrenia; PsychosisSchizophrenia and Related DisordersSchizo Affective Disorder+1 more
University of Bern 25
Not applicableStudy completedNCT02782442
What this trial is testing

Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)

Who this might be right for
TreatmentActive ControlSchizophrenia+7 more
University of Minnesota 109
Early research (Phase 1)Study completedNCT02567370
What this trial is testing

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

Who this might be right for
Schizophrenia or Schizoaffective Disorder
Amgen 70
Testing effectiveness (Phase 2)WithdrawnNCT02197286
What this trial is testing

Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

Who this might be right for
SchizophreniaSchizoaffective Disorder
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT03868839
What this trial is testing

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective DisorderTreatment-resistant Schizophrenia
Xiaoduo Fan 6
Not applicableStudy completedNCT02566057
What this trial is testing

Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Northwell Health 36
Post-approval studies (Phase 4)Study completedNCT00320736
What this trial is testing

Galantamine for Cognition in People With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
North Suffolk Mental Health Association 20
Not applicableStudy completedNCT03179696
What this trial is testing

Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Eric Granholm 31
Not applicableStudy completedNCT05109065
What this trial is testing

Peripheral Immune System in Individuals With Schizophrenia

Who this might be right for
SchizophreniaSchizo Affective DisorderSchizophreniform Disorders
Stanford University 63
Testing effectiveness (Phase 2)Study completedNCT03510741
What this trial is testing

Sodium Benzoate and/or N-Acetylcysteine Added to TAU in Patients With Early Schizophrenia Spectrum Disorder.

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder
Pakistan Institute of Living and Learning 64
Not applicableStudy completedNCT04497857
What this trial is testing

Academic-Community EPINET (AC-EPINET)

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders+2 more
Indiana University 74
Not applicableStudy completedNCT03050853
What this trial is testing

The Appeal and Impact of E-cigarettes in Smokers With SMI

Who this might be right for
Tobacco DependenceSchizophreniaBipolar Disorder+1 more
Dartmouth-Hitchcock Medical Center 240
Early research (Phase 1)Study completedNCT00463372
What this trial is testing

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Who this might be right for
SchizophreniaSchizo-affective Disorder
Pfizer 40
Next Page